09.08.2017
- Martin Shkreli, the eccentric former CEO of Turing Pharmaceuticals, who made headlines in 2015 by jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat...
08.07.2016
- Within the course of a week, US-based KaloBios Pharmaceuticals has emerged from Chapter 11 bankruptcy protection, renegotiated a deal to acquire rights to a new developmental drug...
08.06.2016
- Martin Shkreli, the 33-year-old former CEO of Turing Pharmaceuticals, has pleaded “not guilty” to a conspiracy charge accusing him of using employees and consultants to conceal his...
